Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference

Core Insights - Senti Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation cell and gene therapies using its proprietary Gene Circuit platform [1][3] - The company will present at the Leerink Partners 2026 Global Healthcare Conference on March 9, 2026, at 2:20 PM ET [1] Company Overview - Senti Bio is dedicated to creating innovative cell and gene therapies for patients with incurable diseases, utilizing a synthetic biology platform to engineer Gene Circuits [3] - The Gene Circuits are designed to selectively target and kill cancer cells while sparing healthy cells, enhancing specificity to target tissues, and allowing for control post-administration [3] - The company's pipeline includes cell therapies engineered with Gene Circuits aimed at addressing challenging liquid and solid tumor indications, with preclinical evidence supporting their efficacy in both NK and T cells [3] - Senti Bio is also exploring the application of Gene Circuits in other disease modalities beyond oncology through ongoing partnerships [3]